Jinwon Life Sciences ranked among the top searched stocks for 6 days in the past month.

As of 10:30 AM on the 18th, Jinwon Life Sciences is trading at 9,580 KRW, down 4.2% from the previous day. This represents a 13.64% increase compared to August 12. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners have tentatively net purchased 36,000 shares. Over the past 5 days, individual investors have net purchased 75,420 shares, while foreigners and institutions have net sold 117,922 shares and 2,739 shares, respectively.

On August 14, Jinwon Life Sciences became a market issue with the announcement "Initiation of clinical trials for three COVID-19 vaccines within the year (comprehensive)."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing